GMP Isn't Analysis: How to Actually Read an IPO Before You Apply

Two mainboard IPOs opened this week — Molbio Diagnostics on 10 August, Milky Mist Dairy Food on 11 August. And somewhere in a WhatsApp group, someone is typing "apply karo, listing gain pakka."

That's not analysis. It's a rumour with a rupee sign attached. Most retail investors decide on an IPO using exactly one input — the grey market premium — and spend the next six months wondering what went wrong. Here's a repeatable framework for the other inputs, using both live issues as examples.

GMP isn't a signal

GMP is the unofficial, unregulated price at which IPO shares trade before listing. No exchange publishes it, nobody audits it — it moves on sentiment alone.

Molbio's GMP has swung between roughly ₹50 and ₹180, sitting near ₹120 on 9 August, about 15% over the ₹807 upper band. Milky Mist has been quoted anywhere from ₹0 to ₹26 depending on the day and the site. If the same "signal" swings that wide inside a week, it isn't a signal — it's crowd mood. Useful as a thermometer, useless as a reason.

The 6 checks that actually matter

1. Fresh issue or OFS?

A fresh issue puts money into the company; an offer for sale (OFS) pays existing shareholders, and the company gets nothing. Molbio's ₹939.7 crore issue is mostly OFS — only ₹200 crore is fresh, the remaining ~₹740 crore goes to promoters and existing investors. Milky Mist's ₹1,553 crore issue is the opposite: ₹1,428 crore fresh, only ₹125 crore OFS. Same word, two different transactions — check this split first.

2. Where does the fresh money go?

Molbio's net proceeds (~₹205.93 crore) go almost entirely to expansion: ₹125.12 crore for an R&D facility and Centre of Excellence, ₹80.81 crore for plant and machinery at its Goa and Visakhapatnam units. Milky Mist's ~₹1,121.41 crore splits three ways: ₹496.86 crore to repay debt, ₹469.24 crore to expand its Perundurai facility, and ₹155.31 crore for coolers and freezers. Less than half goes to debt — read the "Objects of the Offer" table yourself before trusting a headline summary.

3. Balance sheet, not brand recall:

Milky Mist's debt-to-equity was 3.61 as of 31 March 2026 (improved from 4.20), against total borrowings of ~₹1,671.85 crore. The ₹496.86 crore repayment clears roughly 30% of that — not all of it. Its RoNW (33.6%) and ROE (32.1%) look strong, but ROCE is a thinner 11.7%. A high ROE on a leveraged balance sheet is partly a function of the leverage.

4. Valuation against listed peers:

At ₹140, Milky Mist's implied market cap (~₹10,778 crore) works out to about 74x FY26 earnings on a pre-issue EPS of ₹1.90. At ₹807, Molbio's post-issue market cap (~₹9,300 crore) is closer to 57x. Neither number says apply or avoid — both tell you how much future growth you're paying for today. Twenty minutes against listed peers gives you the real answer.

5. Concentration risk:

Ask three questions: geographic (Milky Mist leans heavily on South India), product (how much revenue rides on one line), and customer (do a few buyers dominate sales). The RHP's Risk Factors section — written by lawyers to protect the company — is the most honest page in the document.

6. Know which game you're playing:

A listing-gain trade depends on sentiment and allotment luck, not the business — fine, if you size it that way. A long-term hold makes listing day irrelevant; only checks 1–5 matter. The failure mode is applying for a quick gain, missing it, then rebranding yourself a "long-term investor" to avoid booking the loss.

The two issues, side by side

Retail quota in both is 35%, QIB 50%, NII 15%. All dates are tentative, subject to standard approvals.

What good looks like

Running these six checks takes about an hour per IPO — a poor use of time doing it alone from scratch on every issue. It's a better use of time reading structured research from analysts accountable for their record. The distinction isn't "tip vs no tip" — it's whether the person is registered, identifiable, and leaves an auditable track record.

On KuberHunt Edge, you can compare 12+ SEBI-registered Research Analysts in one place before following any of them, with every recommendation carrying a signed timestamp. You stay in control — trades execute through your own broker and demat, and the platform never touches your money or shares. That's the real difference between research and a forward.

FAQs

Is GMP a reliable indicator of listing gains?

No. It's unofficial and unregulated, moves on sentiment, and has no bearing on fundamentals.

What's the difference between a fresh issue and an offer for sale?

A fresh issue creates new shares and the money goes to the company. An OFS is existing shareholders selling — the company gets nothing.

Where can I find an IPO's real financial details?

The Red Herring Prospectus (RHP), filed with SEBI and available on the company's and exchanges' websites. Focus on Objects of the Offer, Risk Factors, restated financials, and peer comparison.

How much money do I need to apply?

Roughly ₹14,000–₹15,000 for one retail lot in most mainboard issues (₹14,526 for Molbio, ₹14,980 for Milky Mist). Retail applications are capped at ₹2 lakh.

Does a strong brand make an IPO a good investment?

Not on its own. Brand recall tells you about the product, not the valuation, debt, or growth runway.

This article is for educational purposes only and is not investment advice or a recommendation to apply for any public issue. KuberHunt is a technology platform that connects investors with SEBI-registered Research Analysts; it is not itself a Research Analyst and does not issue recommendations. Investments in securities are subject to market risks. Read all offer documents carefully before investing.